Targeting epidermal growth factor‐overexpressing triple‐negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting epidermal growth factor‐overexpressing triple‐negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor
Authors
Keywords
-
Journal
CELL PROLIFERATION
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-06-27
DOI
10.1111/cpr.12858
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Over-expression of EGFR regulated by RARA contributes to 5-FU resistance in colon cancer
- (2020) Xin-Yue Gu et al. Aging-US
- Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer
- (2019) Yan Liu et al. Cancer Medicine
- The spatiotemporal evolution of EGFR C797S mutation in EGFR-mutant non-small cell lung cancer: opportunities for third-generation EGFR inhibitors re-challenge
- (2019) Yi-Chen Zhang et al. Science Bulletin
- Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing
- (2019) Tiziano Ingegnere et al. Frontiers in Immunology
- Chimeric antigen receptor (CAR)-modified NK cells against cancer: Opportunities and challenges
- (2019) Luyao Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- EGFR-specific CAR-T cells trigger cell lysis in EGFR-positive TNBC
- (2019) Yan Liu et al. Aging-US
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
- (2018) Yanyu Pang et al. Molecular Cancer
- Targeted peptide-Au cluster binds to epidermal growth factor receptor (EGFR) in both active and inactive states: a clue for cancer inhibition through dual pathways
- (2018) Peng Zhang et al. Science Bulletin
- Novel Human NK Cell Line Carrying CAR Targeting EGFRvIII Induces Antitumor Effects in Glioblastoma Cells
- (2018) TOSHIHARU MURAKAMI et al. ANTICANCER RESEARCH
- Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
- (2018) Aleksandra Simiczyjew et al. Cancers
- Cell-based immunotherapy approaches for multiple myeloma
- (2018) Katharina Kriegsmann et al. BRITISH JOURNAL OF CANCER
- Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer
- (2018) Daniel Shepshelovich et al. Cancer Medicine
- Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
- (2018) Qing Zhang et al. Journal of Immunology Research
- Oncogenic Protein Kinase D3 Regulating Networks in Invasive Breast Cancer
- (2017) Yan Liu et al. International Journal of Biological Sciences
- Engineering Natural Killer Cells for Cancer Immunotherapy
- (2017) Katayoun Rezvani et al. MOLECULAR THERAPY
- Chimeric antigen receptor T-cell therapies for lymphoma
- (2017) Jennifer N. Brudno et al. Nature Reviews Clinical Oncology
- Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells
- (2017) Kevin G. Pinz et al. Oncotarget
- Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment
- (2016) Mei Liu et al. CELL PROLIFERATION
- Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor
- (2016) Chiara Corrado et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Driving CAR T-cells forward
- (2016) Hollie J. Jackson et al. Nature Reviews Clinical Oncology
- A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases
- (2016) Xilin Chen et al. Oncotarget
- Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)
- (2016) Ace J. Hatch et al. Cancer Medicine
- Integrin α5β1 simultaneously controls EGFR-dependent proliferation and Akt-dependent pro-survival signaling in epidermoid carcinoma cells
- (2016) Galina E Morozevich et al. Aging-US
- Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations
- (2014) V Secq et al. BRITISH JOURNAL OF CANCER
- Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women
- (2013) E. Tilch et al. BREAST CANCER RESEARCH AND TREATMENT
- Spectrum of EGFR Gene Copy Number Changes and KRAS Gene Mutation Status in Korean Triple Negative Breast Cancer Patients
- (2013) Yoonjung Kim et al. PLoS One
- Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers
- (2012) Libero Santarpia et al. BREAST CANCER RESEARCH AND TREATMENT
- Role of epidermal growth factor receptor in breast cancer
- (2012) Hiroko Masuda et al. BREAST CANCER RESEARCH AND TREATMENT
- Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer
- (2012) Hiroki Nakajima et al. Breast Cancer
- EGFR is involved in control of gastric cell proliferation through activation of MAPK and Src signalling pathways in early-weaned rats
- (2011) L. H. Osaki et al. CELL PROLIFERATION
- Triple negative breast cancers: Clinical and prognostic implications
- (2009) S.J. Dawson et al. EUROPEAN JOURNAL OF CANCER
- The Role of EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer
- (2009) M. Ray et al. ONCOLOGIST
- Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers
- (2008) Tatsuya Toyama et al. BMC CANCER
- Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- (2008) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis
- (2008) Michael Vibo Grandal et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More